MOLECULIN BIOTECH INC (MBRX) Stock Balance Sheet
NASDAQ:MBRX - Nasdaq - US60855D3098 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 7.72M | 4.28M | 23.55M | 43.15M | 70.90M | |||
| Receivables | 4.00K | 15.00K | 1.52M | 1.05M | 496.00K | |||
| Other Current Assets | 1.62M | 901.00K | 1.20M | 1.40M | 1.10M | |||
| Total Current Assets | 9.34M | 5.19M | 26.27M | 45.60M | 72.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 525.00K | 583.00K | 796.00K | 678.00K | 445.00K | |||
| Intangibles | 11.15M | 11.15M | 11.15M | 11.15M | 11.15M | |||
| Total Non-Current Assets | 11.67M | 11.73M | 11.94M | 11.83M | 11.59M | |||
| TOTAL ASSETS | 21.01M | 16.93M | 38.22M | 57.42M | 84.09M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 4.02M | 3.20M | 4.26M | 2.64M | 2.15M | |||
| Accounts Payable | 2.71M | 2.03M | 2.50M | 2.10M | 1.36M | |||
| Other Current Liabilities | 174.00K | 130.00K | 60.00K | 86.00K | 109.00K | |||
| Total Current Liabilities | 6.90M | 5.36M | 6.82M | 4.82M | 3.62M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 14.07M | 5.59M | 5.33M | 412.00K | 1.48M | |||
| Total Non-Current Liabilities | 14.07M | 5.59M | 5.33M | 412.00K | 1.48M | |||
| TOTAL LIABILITIES | 20.97M | 10.95M | 12.14M | 5.23M | 5.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -159.80M | -153.37M | -131.60M | -101.83M | -72.81M | |||
| Additional Paid In Capital | 159.87M | 159.38M | 157.65M | 153.99M | 151.73M | |||
| Common Shares | 14.00K | 3.00K | 33.00K | 29.00K | 29.00K | |||
| Other Shareholders' Equity | -38.00K | -41.00K | -9.00K | 12.00K | 41.00K | |||
| Shares Outstanding | 14.13M | 3.38M | 2.23M | 1.91M | 1.91M | |||
| Tangible Book Value per Share | -0.79 | -1.53 | 6.70 | 21.50 | 35.61 | |||
| Total Shareholders' Equity | 42.00K | 5.98M | 26.07M | 52.19M | 78.99M | |||
| TOTAL LIABILITIES AND EQUITY | 21.01M | 16.93M | 38.22M | 57.42M | 84.09M | |||
| Statistics | ||||||||
| Current Ratio | 1.35 | 0.97 | 3.86 | 9.46 | 20.02 | |||
| Return On Assets (ROA) | -110.55% | -128.58% | -77.89% | -50.55% | -18.90% | |||
| Return On Equity (ROE) | -55307.14% | -363.99% | -114.18% | -55.61% | -20.12% | |||
All data in USD , ROIC based on taxRate of 0.21